NCT07450859 · Interventional trial
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Overall registry status Recruiting
Phase 2
Conditions Pancreatic Ductal Adenocarcinoma (PDAC)
Delaware Valley sites
- Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory